Screener
Palvella Therapeutics PVLA Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Palvella Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Palvella Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210463
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $206,394 | $57,982 |
| Short-term investments | 55,459 | — |
| Prepaid expenses and other current assets | 1,378 | 1,005 |
| Total current assets | 263,231 | 58,987 |
| Operating lease right-of-use assets, net | 528 | 572 |
| Total assets | $263,759 | $59,559 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: |
Item 1. Financial Statements.
FAQ
- What is Palvella Therapeutics's total current assets?
- Palvella Therapeutics (PVLA) reported total current assets of $263.23M in Q1 2026.
- How has Palvella Therapeutics's total current assets changed year-over-year?
- Palvella Therapeutics's total current assets increased by 231.4% year-over-year, from $79.44M to $263.23M.
- What is the long-term trend for Palvella Therapeutics's total current assets?
- Over 5 years (2020 to 2025), Palvella Therapeutics's total current assets has grown at a -4.9% compound annual growth rate (CAGR), from $75.72M to $58.99M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Palvella Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude